Precision Medical Ventures

Website

Precision Medical Ventures Inc.

2 Investors
Medical Technology Investment
SEATTLE, WA

Precision Medical Ventures Inc. (PMV) is an innovative investment group dedicated to advancing medical technology, particularly within the realms of radiology and healthcare. The company is committed to enhancing patient care and outcomes by developing cutting-edge medical devices and software solutions that address critical challenges in healthcare delivery.

Products & Team

RevealAI-Lung

Diagnostic SoftwareSeed

RevealAI-Lung is a revolutionary computer-aided diagnosis (CADx) software designed specifically for the characterization of lung nodules. It employs advanced algorithms to analyze lung CT scans with high precision, addressing the critical need for accurate assessment and management of lung nodules that could indicate cancer.

Value Proposition

RevealAI-Lung effectively solves the problem of inefficient and costly management of lung nodules, which are detected in a large percentage of chest CT scans, subsequently leading to unnecessary and expensive procedures.

Pain Points

The primary customer issues tackled include the high costs and inefficiencies associated with lung nodule diagnosis, management, and subsequent treatment processes.

World's first CADx software for lung nodule characterization to receive regulatory clearanceImproves diagnostic precision for better treatment outcomesSignificantly reduces healthcare costs associated with lung nodule managementScientifically validated to enhance patient outcomes
Industry
Other Technology
Primary business sector
Founded
2025
Year established
Location
SEATTLE, WA
Primary headquarters

Funding History

Total Raised:
$500.2K
E

Debt Financing, Option to Acquire Offering

March 2025
$2.0M
Target
Progress
25%
Raised
$500.2K
Target
$2.0M
#000188574025000001